Article ; Online: Impact of hospital-acquired acute kidney injury on Covid-19 outcomes in patients with and without chronic kidney disease: a multicenter retrospective cohort study
Turkish journal of medical sciences
2021 Volume 51, Issue 3, Page(s) 947–961
Abstract: Background/aim: Hospital-acquired acute kidney injury (HA-AKI) may commonly develop in Covid-19 ... the effect of HA-AKI on mortality of chronic kidney disease (CKD) patients and a control group ... in hospitalized patients due to Covid-19 and is associated with high mortality. HA-AKI has worse outcomes ...
Abstract | Background/aim: Hospital-acquired acute kidney injury (HA-AKI) may commonly develop in Covid-19 patients and is expected to have higher mortality. There is little comparative data investigating the effect of HA-AKI on mortality of chronic kidney disease (CKD) patients and a control group of general population suffering from Covid-19. Materials and methods: HA-AKI development was assessed in a group of stage 3–5 CKD patients and control group without CKD among adult patients hospitalized for Covid-19. The role of AKI development on the outcome (in-hospital mortality and admission to the intensive care unit [ICU]) of patients with and without CKD was compared. Results: Among 621 hospitalized patients (age 60 [IQR: 47–73]), women: 44.1%), AKI developed in 32.5% of the patients, as stage 1 in 84.2%, stage 2 in 8.4%, and stage 3 in 7.4%. AKI developed in 48.0 % of CKD patients, whereas it developed in 17.6% of patients without CKD. CKD patients with HA-AKI had the highest mortality rate of 41.1% compared to 14.3% of patients with HA-AKI but no CKD (p < 0.001). However, patients with AKI+non-CKD had similar rates of ICU admission, mechanical ventilation, and death rate to patients with CKD without AKI. Adjusted mortality risks of the AKI+non-CKD group (HR: 9.0, 95% CI: 1.9–44.2) and AKI+CKD group (HR: 7.9, 95% CI: 1.9–33.3) were significantly higher than that of the non-AKI+non-CKD group. Conclusion: AKI frequently develops in hospitalized patients due to Covid-19 and is associated with high mortality. HA-AKI has worse outcomes whether it develops in patients with or without CKD, but the worst outcome was seen in AKI+CKD patients. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | Acute Kidney Injury/epidemiology ; Acute Kidney Injury/etiology ; Aged ; COVID-19/complications ; COVID-19/epidemiology ; Female ; Hospital Mortality/trends ; Humans ; Incidence ; Intensive Care Units/statistics & numerical data ; Male ; Middle Aged ; Pandemics ; Renal Insufficiency, Chronic/complications ; Renal Insufficiency, Chronic/epidemiology ; Retrospective Studies ; Risk Factors ; SARS-CoV-2 ; Survival Rate/trends | |||||
Language | English | |||||
Publishing date | 2021-06-28 | |||||
Publishing country | Turkey | |||||
Document type | Journal Article ; Multicenter Study | |||||
ZDB-ID | 1183461-4 | |||||
ISSN | 1303-6165 ; 1300-0144 | |||||
ISSN (online) | 1303-6165 | |||||
ISSN | 1300-0144 | |||||
DOI | 10.3906/sag-2011-169 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3242: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.